VYOME HOLDINGS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
VYOME HOLDINGS, INC. (HIND) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$34.13 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-12
- VYOME HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$34.13K.
- VYOME HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$22.61K.
- VYOME HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$54.22K.
- VYOME HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$161.49K.
- VYOME HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$215.71K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$34.13K 10-Q · filed 2026-08-12 | -$56.74K 10-Q · filed 2026-08-12 | -$110.95K derived: sum of 3 quarters · filed 2026-08-12 | -$272.44K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$22.61K 10-Q · filed 2026-05-12 | -$76.83K derived: sum of 2 quarters · filed 2026-05-12 | -$238.32K derived: sum of 3 quarters · filed 2026-05-12 | |
| 2025-12-31 | -$54.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$215.71K derived: sum of 2 quarters · filed 2026-03-18 | -$215.71K 10-K · filed 2026-03-18 | |
| 2025-09-30 | -$161.49K 10-Q · filed 2025-11-14 | -$161.49K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |